StockCode
688506
Investors
中文 | EN
中文|EN

Baili Duote Biotechnology Granted 2025 Sichuan Province "Specialized, Refined, Distinctive, and Innovative" SME Designation

时间:2025-11-10

 October 23, 2025 – The Department of Economy and Information Technology of Sichuan Province officially released the list of Small and Medium-sized Enterprises (SMEs) recognized as "Specialized, Refined, Distinctive, and Innovative" (SRDI) for the year 2025, as well as those that passed the reassessment. Chengdu Baili Duote Biotechnology Pharmaceutical Co., Ltd. successfully obtained the designation and was included in the 2025 list of Sichuan Province's SRDI SMEs. The designation is valid until October 31, 2028.

The SRDI recognition process was strictly conducted in accordance with the standards outlined in the "Sichuan Province High-Quality SME Gradient Cultivation Management Implementation Plan" (Chuan Jingxin Qiye Han [2022] No. 728). The selection involved a rigorous multi-stage procedure including voluntary application by enterprises, recommendations from cities (prefectures), expert evaluation, on-site spot checks, solicitation of opinions from relevant departments, and public announcement. This process aims to select and cultivate a group of SMEs with strong technical capabilities, high product quality, and leading market shares within specific niche sectors.

图1.png

SystImmune
Baili Pharmaceutical
Guorui Pharmaceutical
Baili-Bio
Jingxi Pharmaceutical
Hiatt Technology
Company Address:1#, Building 1,No.161, Baili Road, Cross-Strait Science and Technology Industrial Development Park, Wenjiang District, Chengdu City
Postcode:610041
Tel:028-85183639
Sichuan Biokin Pharmaceutical Co.,Ltd Copyright © 2018 All rights reserved
SICPB No. 17035664-1   
Internet Drug Information Service Qualification Certificate S/N: (C)-FJYX-2022-0343